These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33999387)

  • 1. The everchanging framework of autoinflammation.
    Manna R; Rigante D
    Intern Emerg Med; 2021 Oct; 16(7):1759-1770. PubMed ID: 33999387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype variability of autoinflammatory disorders in the pediatric patient: A pictorial overview.
    Rigante D
    J Evid Based Med; 2020 Aug; 13(3):227-245. PubMed ID: 32627322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.
    Nigrovic PA; Lee PY; Hoffman HM
    J Allergy Clin Immunol; 2020 Nov; 146(5):925-937. PubMed ID: 33160483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic fever syndromes and the autoinflammatory diseases (AIDs).
    Marino A; Tirelli F; Giani T; Cimaz R
    J Transl Autoimmun; 2020; 3():100031. PubMed ID: 32743516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations.
    Papa R; Picco P; Gattorno M
    Adv Protein Chem Struct Biol; 2020; 120():1-44. PubMed ID: 32085880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Autoinflammatory Disorders: Recognition and Treatment.
    Broderick L
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):13-29. PubMed ID: 30466770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases.
    Savic S; Coe J; Laws P
    J Invest Dermatol; 2022 Mar; 142(3 Pt B):781-792. PubMed ID: 34887082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burgeoning field of innate immune-mediated disease and autoinflammation.
    Peckham D; Scambler T; Savic S; McDermott MF
    J Pathol; 2017 Jan; 241(2):123-139. PubMed ID: 27682255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children.
    Du Y; Liu M; Nigrovic PA; Dedeoglu F; Lee PY
    J Allergy Clin Immunol; 2023 Mar; 151(3):607-618. PubMed ID: 36707349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.
    de Jesus AA; Canna SW; Liu Y; Goldbach-Mansky R
    Annu Rev Immunol; 2015; 33():823-74. PubMed ID: 25706096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From autoinflammation to autoimmunity: old and recent findings.
    Caso F; Costa L; Nucera V; Barilaro G; Masala IF; Talotta R; Caso P; Scarpa R; Sarzi-Puttini P; Atzeni F
    Clin Rheumatol; 2018 Sep; 37(9):2305-2321. PubMed ID: 30014358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinflammatory diseases in childhood, part 2: polygenic syndromes.
    Navallas M; Inarejos Clemente EJ; Iglesias E; Rebollo-Polo M; Hernández JC; Navarro OM
    Pediatr Radiol; 2020 Mar; 50(3):431-444. PubMed ID: 32065273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinflammatory syndromes behind the scenes of recurrent fevers in children.
    Rigante D
    Med Sci Monit; 2009 Aug; 15(8):RA179-87. PubMed ID: 19644432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.
    Jamilloux Y; Belot A; Magnotti F; Benezech S; Gerfaud-Valentin M; Bourdonnay E; Walzer T; Sève P; Henry T
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):454-479. PubMed ID: 28578473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoinflammation and autoimmunity: bridging the divide.
    Doria A; Zen M; Bettio S; Gatto M; Bassi N; Nalotto L; Ghirardello A; Iaccarino L; Punzi L
    Autoimmun Rev; 2012 Nov; 12(1):22-30. PubMed ID: 22878274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
    Günther C; Schmidt F; König N; Lee-Kirsch MA
    Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases.
    Georgel P
    Cells; 2021 May; 10(5):. PubMed ID: 34066649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.
    Lopalco G; Cantarini L; Vitale A; Iannone F; Anelli MG; Andreozzi L; Lapadula G; Galeazzi M; Rigante D
    Mediators Inflamm; 2015; 2015():194864. PubMed ID: 25784780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.